I should like to extend a heartfelt welcome to our web page in which you will be able to extend your knowledge of our Company.

Laboratorios Farmacéuticos ROVI, S.A. is a chemical and pharmaceutical company incorporated in Madrid in 1946 and its activities concentrate on its own pharmaceutical products, manufacturing for third parties and distribution of other products for which it holds a licence from other laboratories (such as Servier, Novartis or Merck), devoting all its efforts to the satisfaction of its internal and external clients for the promotion of health within Society.

Following our global strategy, we at ROVI have made a strong wager in favour of research and development in the knowledge that the present and the future are enshrined here, thus allowing us to offer products that meet the expectations of Regulatory Authorities, Health-Care Professionals and patients.

I would like to thank the Spanish Government and also the Regional Governments of our country, the efforts they do promoting and encouraging innovation, making available important economic resources to the health sector, through the Ministry of Industry, an important driver for competitiveness promotion of industrial strategic sector, in collaboration with the Ministry of Economy and Competitiveness, promoting the R&D investments executed in Centers of Excellence for R&D&i, in the Scientific Technological Parks distributed through Spanish territory, and through the Ministry of Health, Social Policy and Equality, with its determined commitment for the support policies to national pharmaceutical companies, emphasizing the importance of obtaining medicines of therapeutic interest within the Health System, its contribution to R&D&i as well as the support to the internationalization of Spanish economy and the creation of quality employment.
ROVI's success is based on its commitment to research and innovation, creating a dynamic ecosystem, in which stand out potentially valuable R&D projects in terms of incremental innovation, of strategic and collaborative nature with other leading companies of the sector, biotechnology companies, spin-offs Universities and Public Research Centres. ROVI is present with this spirit in the creation of National Strategic Consortia in Technical Research (CENIT), participating since 2006 as a partner in the Research activities of CENIT Nanofarma, CENIT Melius 2007, CENIT CeyeC 2009, and since 2011 as leader of SNC_Integra project, and ADELIS in 2013, in the ambit of the Program FEDER-INNTERCONECTA for Andalucía.

2014 has been a significant year for ROVI, its performance focused in a strong leadership in R&D, the development of a strategic industrialization plan and the internationalization of its products, have been made possible by a team of approximately 1,000 professionals of ROVI that support our growth, with a solid financial position allowing us to be more competitive, and create greater value for shareholders.

At ROVI we believe that is necessary to continue improving and making progress in innovation, so we began a new time with all our enthusiasm in the H2020 Program, intended to fund research projects and initiatives, technological development, demonstration and innovation of clear European added value.

We should like to count on you to continue with this progress, so I invite you to browse through the contents of these pages and get to know us better.

Welcome to ROVI`s on-line area!